Trial Profile

An Efficacy and 2-Year Safety Study of Open-label Rosuvastatin in Children and Adolescents (Aged From 6 to Less Than 18 Years) With Familial Hypercholesterolaemia.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 03 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Rosuvastatin (Primary)
Indications Hypercholesterolaemia
Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Registrational; Therapeutic Use
Acronyms CHARON
Sponsors AstraZeneca

07 Jun 2017 Results (n=198) assessing the efficacy of Rosuvastatin on carotid intima-media thickness in children with heterozygous familial hypercholesterolemia, published in the Circulation
21 Sep 2015 Results of population pharmacokinetics of rosuvastatin in pediatric patients from two studies published in the European Journal of Clinical Pharmacology.
31 Mar 2014 Results for the effect of rosuvastatin on carotid intima media thickness presented at the 63rd Annual Scientific Session of the American College of Cardiology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com